NCT00346840View on ClinicalTrials.gov

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

March 31, 2004

Conditions
Labor InductionCervical Ripening
Interventions
DRUG

Misoprostol vaginal insert 25 mcg

One hydrogel polymer vaginal insert for up to 24h

DRUG

Misoprostol vaginal insert 50 mcg

One hydrogel polymer vaginal insert for up to 24h

DRUG

Misoprostol vaginal insert 100 mcg

One hydrogel polymer vaginal insert for up to 24h

DRUG

Misoprostol vaginal insert 200 mcg

One hydrogel polymer vaginal insert for up to 24h

Trial Locations (6)

B13 9HP

Birmingham Women's Hospital, Birmingham

G11 5DY

Princess Royal Maternity Hospital, Glasgow

IG3 8YB

King George Hospital, Ilford

L8 7SS

Liverpool Women's Hospital, Liverpool

NN1 5BD

Northampton General Hospital, Northampton

G12 9TZ

The Queen's Mother's Hospital, Yorkhill, Glasgow

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY